Bruce M Halpryn
Chief Executive Officer at Eikonoklastes Therapeutics, Inc.
Bruce M Halpryn active positions
| Companies | Position | Start | End |
|---|---|---|---|
Eikonoklastes Therapeutics, Inc.
 Eikonoklastes Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eikonoklastes Therapeutics, Inc. provides pharmaceutical services. It develops a state of the art immune conjugate technology targeting tissue factor for the treatment of solid tumors and other pathologic conditions. The company was founded by Zhiwei Hu and is headquartered in Cincinnati, OH. | Chief Executive Officer | 28/02/2019 | - |
| Chairman | 28/02/2019 | - | |
| Founder | 28/02/2019 | - |
Career history of Bruce M Halpryn
Former positions of Bruce M Halpryn
| Companies | Position | Start | End |
|---|---|---|---|
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Director/Board Member | 31/01/2017 | 31/03/2024 |
| Chief Operating Officer | 31/01/2017 | 31/03/2024 | |
| Founder | 31/01/2017 | 31/03/2024 | |
| Corporate Secretary | 31/01/2017 | 31/03/2024 |
Statistics
International
| United States | 3 |
Operational
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Health Technology |
Eikonoklastes Therapeutics, Inc.
Eikonoklastes Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eikonoklastes Therapeutics, Inc. provides pharmaceutical services. It develops a state of the art immune conjugate technology targeting tissue factor for the treatment of solid tumors and other pathologic conditions. The company was founded by Zhiwei Hu and is headquartered in Cincinnati, OH. | Health Technology |
- Stock Market
- Insiders
- Bruce M Halpryn
- Experience
